Semiquantitative immunohistochemical analysis revealed a 1.6-fold higher level of Septin4 in peritumoral benign colon cancer cells when compared with colon cancer cells (Figure 1A, B; mean score 8 vs 5, P<0.001). This evidence concerns the gene SEPTIN4 and colonic neoplasm.